1. Home
  2. SENS vs BNR Comparison

SENS vs BNR Comparison

Compare SENS & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

HOLD

Current Price

$6.88

Market Cap

252.5M

Sector

Industrials

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$16.35

Market Cap

233.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SENS
BNR
Founded
1996
2014
Country
United States
China
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.5M
233.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SENS
BNR
Price
$6.88
$16.35
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$25.58
N/A
AVG Volume (30 Days)
377.0K
68.7K
Earning Date
11-05-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,298,000.00
$75,749,382.00
Revenue This Year
$59.55
$136.32
Revenue Next Year
$70.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
31.94
5.56
52 Week Low
$5.25
$2.18
52 Week High
$28.00
$23.59

Technical Indicators

Market Signals
Indicator
SENS
BNR
Relative Strength Index (RSI) 62.58 49.77
Support Level $6.52 $15.64
Resistance Level $6.95 $18.42
Average True Range (ATR) 0.39 2.44
MACD 0.02 -0.61
Stochastic Oscillator 83.60 20.46

Price Performance

Historical Comparison
SENS
BNR

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: